scispace - formally typeset
R

Raffaele Ferrari

Researcher at University College London

Publications -  46
Citations -  1923

Raffaele Ferrari is an academic researcher from University College London. The author has contributed to research in topics: Genome-wide association study & Frontotemporal dementia. The author has an hindex of 19, co-authored 46 publications receiving 1241 citations. Previous affiliations of Raffaele Ferrari include National Institutes of Health & Texas Tech University Health Sciences Center.

Papers
More filters
Journal ArticleDOI

Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences.

TL;DR: This review cuts across the boundaries between genomics, transcriptomics and proteomics, summarizing how omics data are generated, analysed and shared and provides an overview of the current strengths and weaknesses of this global approach.
Journal ArticleDOI

Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

Ruth Chia, +166 more
- 15 Feb 2021 - 
TL;DR: This article performed whole-genome sequencing in large cohorts of Lewy body dementia (LBD) cases and neurologically healthy controls to study the genetic architecture of this understudied form of dementia, and to generate a resource for the scientific community.
Journal ArticleDOI

NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases

TL;DR: The NeuroChip has a more comprehensive and improved content, which makes it a reliable, high-throughput, cost-effective screening tool for genetic research and molecular diagnostics in neurodegenerative diseases.
Journal ArticleDOI

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

Cyril Pottier, +145 more
- 01 Jun 2018 - 
TL;DR: In this paper, a meta-analysis was conducted to identify potential genetic modifiers of disease onset and disease risk in frontotemporal lobar degeneration (FTLD) carriers.